Clinical Trial Update: Heart Failure Center Accreditation in China (HF-CAP Trial) [NA]

View source ↗

Summary

The HF-CAP Trial at Shanghai Zhongshan Hospital is not yet recruiting and relates to Heart Failure center accreditation in China.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Heart Failure | NA | Status: NOT_YET_RECRUITING